JP2008526773A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526773A5 JP2008526773A5 JP2007549693A JP2007549693A JP2008526773A5 JP 2008526773 A5 JP2008526773 A5 JP 2008526773A5 JP 2007549693 A JP2007549693 A JP 2007549693A JP 2007549693 A JP2007549693 A JP 2007549693A JP 2008526773 A5 JP2008526773 A5 JP 2008526773A5
- Authority
- JP
- Japan
- Prior art keywords
- formulated
- oral
- therapeutic agent
- administered
- bdp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64017804P | 2004-12-30 | 2004-12-30 | |
| PCT/US2005/047666 WO2006072093A2 (en) | 2004-12-30 | 2005-12-30 | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526773A JP2008526773A (ja) | 2008-07-24 |
| JP2008526773A5 true JP2008526773A5 (enExample) | 2009-06-04 |
Family
ID=36615583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549693A Pending JP2008526773A (ja) | 2004-12-30 | 2005-12-30 | ベクロメタゾンジプロピオネート及びプレドニゾンでの、移植片対宿主病及び白血病の治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060252735A1 (enExample) |
| EP (1) | EP1830857B1 (enExample) |
| JP (1) | JP2008526773A (enExample) |
| KR (1) | KR20070089701A (enExample) |
| CN (2) | CN102218070A (enExample) |
| AT (1) | ATE481102T1 (enExample) |
| AU (1) | AU2005321826B2 (enExample) |
| CA (1) | CA2583244A1 (enExample) |
| DE (1) | DE602005023655D1 (enExample) |
| DK (1) | DK1830857T3 (enExample) |
| IL (1) | IL182462A0 (enExample) |
| NZ (1) | NZ554326A (enExample) |
| WO (1) | WO2006072093A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090143328A1 (en) * | 2001-08-13 | 2009-06-04 | Mcdonald George | Method of Treating Cancer by Administration of Topical Active Corticosteroids |
| AU2009333538B2 (en) * | 2008-12-08 | 2014-09-11 | Soligenix, Inc. | Topically active steroids for use in radiation and chemotherapeutics injury |
| US20170209447A1 (en) * | 2014-08-07 | 2017-07-27 | Nitor Therapeutics | Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant |
| CN106236736A (zh) * | 2016-09-26 | 2016-12-21 | 安徽省逸欣铭医药科技有限公司 | 二丙酸倍氯米松肠溶缓释片及其制备方法 |
| KR20220123004A (ko) * | 2019-12-09 | 2022-09-05 | 신닥스 파마슈티컬스, 인크. | 만성 이식편 대 숙주 질환의 치료를 위한 항체 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| US5747474A (en) * | 1996-07-29 | 1998-05-05 | Immune Modulation, Inc. | Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides |
| US6096731A (en) * | 1998-06-24 | 2000-08-01 | Institute For Drug Research, Inc. | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| US20020086857A1 (en) * | 2000-09-15 | 2002-07-04 | Mcdonald George B. | Method of long-term treatment of graft-versus-host disease using topical active corticosterioids |
| IL157921A0 (en) * | 2001-03-15 | 2004-03-28 | Enteron Pharmaceuticals Inc | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| US20030032631A1 (en) * | 2001-08-13 | 2003-02-13 | Mcdonald George B. | Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods |
| JP4014912B2 (ja) * | 2001-09-28 | 2007-11-28 | 株式会社ルネサステクノロジ | 半導体装置 |
-
2005
- 2005-12-30 AT AT05856121T patent/ATE481102T1/de not_active IP Right Cessation
- 2005-12-30 JP JP2007549693A patent/JP2008526773A/ja active Pending
- 2005-12-30 CA CA002583244A patent/CA2583244A1/en not_active Abandoned
- 2005-12-30 KR KR1020077013835A patent/KR20070089701A/ko not_active Ceased
- 2005-12-30 DK DK05856121.8T patent/DK1830857T3/da active
- 2005-12-30 WO PCT/US2005/047666 patent/WO2006072093A2/en not_active Ceased
- 2005-12-30 EP EP05856121A patent/EP1830857B1/en not_active Expired - Lifetime
- 2005-12-30 CN CN2011101121156A patent/CN102218070A/zh active Pending
- 2005-12-30 US US11/320,564 patent/US20060252735A1/en not_active Abandoned
- 2005-12-30 NZ NZ554326A patent/NZ554326A/en not_active IP Right Cessation
- 2005-12-30 AU AU2005321826A patent/AU2005321826B2/en not_active Ceased
- 2005-12-30 CN CN2005800393955A patent/CN101060848B/zh not_active Expired - Fee Related
- 2005-12-30 DE DE602005023655T patent/DE602005023655D1/de active Active
-
2007
- 2007-04-11 IL IL182462A patent/IL182462A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9827315B2 (en) | Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives | |
| ES2991544T3 (es) | Ketamina para el tratamiento de síntomas relacionados con la menstruación | |
| Fedorak et al. | Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide | |
| US12390476B2 (en) | Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen | |
| McKeage et al. | Budesonide (Entocort® EC Capsules) A Review of its Therapeutic Use in the Management of Active Crohn’s Disease in Adults | |
| JP2019528272A5 (enExample) | ||
| Rasheed et al. | A review of natural steroids and their applications | |
| JP2015531400A (ja) | プロゲステロン含有経口投与形態およびキット | |
| JP2010506867A (ja) | 女性の性欲を維持、及び／又は亢進するための経口治療のための、吉草酸エストラジオール又は１７β−エストラジオールとジエノゲストとの組み合わせの使用 | |
| Elad et al. | Budesonide: a novel treatment for oral chronic graft versus host disease | |
| JP5721322B2 (ja) | 更年期障害関連症候群の治療 | |
| US6096731A (en) | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation | |
| JP2008526773A5 (enExample) | ||
| KR20100121601A (ko) | 면역염증성 질환의 치료를 위한 치료요법 | |
| JP2002502812A (ja) | 胃腸管の慢性炎症疾患の治療 | |
| US20100184732A1 (en) | Method of long-term treatment of graft-versus-host disease using topical active corticosteroids | |
| AU2005321826B2 (en) | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone | |
| US11376263B2 (en) | Cyproterone acetate compositions and uses thereof | |
| US20040006053A1 (en) | Method of long-term treatment of Graft-Versus-Host Disease using topical active corticosteriods | |
| CN112274511B (zh) | 用于治疗移植物抗宿主病的喹啉衍生物 | |
| CA2413883C (en) | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation | |
| CN118234515A (zh) | 用于治疗和预防严重注射部位反应的方法和治疗组合物 | |
| CN118043051A (zh) | 用于治疗或预防抗宿主病的吡咯并六元杂芳物 | |
| CA2624380A1 (en) | Method for manufacturing a monophasic pharmaceutical product for oral therapy of dysfunctional uterine bleeding | |
| CN112439069A (zh) | 一种vegfr抑制剂在制备治疗移植物抗宿主病的药物中的用途 |